Anti-vascular effects of calcium electroporation in murine melanoma

被引：0
|
作者：
Staresinic, B. [1 ,2 ]
Jesenko, T. [1 ]
Kamensek, U. [1 ]
Frandsen, S. Krog [3 ]
Sersa, G. [1 ,4 ]
Gehl, J. [3 ,5 ]
Cemazar, M. [1 ,6 ]
机构：
[1] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[3] Zealand Univ Hosp, Dept Clin Oncol, Roskilde, Denmark
[4] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[6] Univ Primorska, Fac Hlth Sci, Izola, Slovenia
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
265 (PB-02
引用
收藏
页码：E90 / E91
页数：2
相关论文
共 50 条
  • [31] Anti-vascular inflammatory effects of pentacyclic triterpenoids from Astilbe rivularis in vitro and in vivo
    Kang, Hyejin
    Ku, Sae-Kwang
    Kim, Jongdoo
    Chung, Jiwoo
    Kim, Sang Chan
    Zhou, Wei
    Na, MinKyun
    Bae, Jong-Sup
    CHEMICO-BIOLOGICAL INTERACTIONS, 2017, 261 : 127 - 138
  • [32] The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
    Drzyzga, Alina
    Cichon, Tomasz
    Czapla, Justyna
    Jarosz-Biej, Magdalena
    Pilny, Ewelina
    Matuszczak, Sybilla
    Wojcieszek, Piotr
    Urbas, Zbigniew
    Smolarczyk, Ryszard
    CANCERS, 2021, 13 (16)
  • [33] Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma
    Sersa, G.
    Jarm, T.
    Kotnik, T.
    Coer, A.
    Podkrajsek, M.
    Sentjurc, M.
    Miklavcic, D.
    Kadivec, M.
    Kranjc, S.
    Secerov, A.
    Cemazar, M.
    BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 388 - 398
  • [34] Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma
    G Sersa
    T Jarm
    T Kotnik
    A Coer
    M Podkrajsek
    M Sentjurc
    D Miklavcic
    M Kadivec
    S Kranjc
    A Secerov
    M Cemazar
    British Journal of Cancer, 2008, 98 : 388 - 398
  • [35] Plasma levels of vascular endothelial growth factor and anti-vascular endothelial growth factor before and after intravitreal injection of anti-vascular endothelial growth factor
    Park, Sang Jun
    Yoon, Myung Hun
    Chung, Ah Reum
    Chin, Hee Seung
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [36] Targeted anti-vascular gene delivery to tumor vasculature
    Tandle, A.
    Hanna, E.
    Lorang, D.
    Hajitou, A.
    Moya, C. A.
    Pasqualini, R.
    Arap, W.
    Adem, A.
    Starker, E.
    O'Connor, S.
    Keck, V.
    Hewitt, S.
    Libutti, S. K.
    ANNALS OF ONCOLOGY, 2008, 19 : 27 - 27
  • [37] Anti-vascular endothelial growth factor for neovascular glaucoma
    Simha, Arathi
    Braganza, Andrew
    Abraham, Lekha
    Samuel, Prasanna
    Lindsley, Kristina
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10):
  • [38] ANTI-VASCULAR ENDOTHELIUM ANTIBODY IN RENAL-TRANSPLANTATION
    CERILLI, GJ
    HOLLIDAY, JE
    LEE, IC
    SURGICAL FORUM, 1975, 26 : 341 - 342
  • [39] Complications of Anti-Vascular Endothelial Growth Factor Drugs
    Tolentino, Michael
    CURRENT DRUG THERAPY, 2012, 7 (02) : 131 - 137
  • [40] Anti-vascular endothelial growth factor and retinopathy of prematurity
    Sears, Jonathan E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (11) : 1437 - 1438
12345